Laquinimod
| Use attributes for filter ! | |
| Formula | C19H17ClN2O3 |
|---|---|
| Molar mass | 356. 803 g/mol |
| ChemSpider ID | 11444966 |
| PubChem CID | 216469 |
| Music groups | Glatiramer acetate |
| Teriflunomide | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2933559 |
About Laquinimod
Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis. Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide.